Dose by design: How limits on nicotine flux and puff duration affect the abuse liability of electronic nicotine delivery systems
- PMID: 39657440
- PMCID: PMC11736901
- DOI: 10.1016/j.drugalcdep.2024.112508
Dose by design: How limits on nicotine flux and puff duration affect the abuse liability of electronic nicotine delivery systems
Abstract
Introduction: Electronic nicotine delivery system (ENDS) product standards for nicotine flux (nicotine emitted/second), combined with limiting puff duration, could control nicotine dose and support ENDS regulations. We assessed behavioral and subjective abuse liability indices for ENDS varying in nicotine flux with fixed puff duration among people who smoke.
Methods: This within-subjects study included 32 adults who smoked cigarettes. Own-brand cigarettes (OB) and four unflavored ENDS were evaluated: no-flux (0μg/s), low-flux (36.01μg/s), cigarette-like-flux (90.03μg/s), and high-flux (180.06μg/s), with ENDS puff duration limited to 2s. Outcomes from behavioral economic choice tasks included demand intensity (drug purchase task [DPT]), cross-price elasticity (cross-product DPT), puffs earned (progressive ratio task [PRT]), and breakpoint (cross-product PRT). Subjective effects were nicotine abstinence symptoms (NAS), aversive effects, product liking, and sensation. Condition differences were analyzed using linear mixed models.
Results: All ENDS were associated with significantly lower demand intensity, puffs earned, NAS suppression, and liking compared to OB, yet would serve as OB substitutes. Low-flux ENDS were a significantly stronger OB substitute than cigarette-like-flux ENDS, and were associated with more puffs earned than no and high-flux ENDS. Compared with other ENDS, high-flux ENDS generally reduced NAS more, were less pleasant, tasted worse and produced more intense harshness/irritancy and throat hit.
Conclusions: ENDS abuse liability and substitution potential varies by nicotine dose, which could be controlled via product standards integrating nicotine flux and puff duration. ENDS that exceed a cigarette nicotine dose may not be necessary to encourage transition from cigarettes to ENDS.
Keywords: Abuse liability; Clinical laboratory; Electronic nicotine delivery systems; Nicotine flux; Subjective effects.
Copyright © 2024. Published by Elsevier B.V.
Conflict of interest statement
Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Similar articles
-
Constraining electronic nicotine delivery systems (ENDS) nicotine dose by controlling nicotine flux at a limited puff duration.Exp Clin Psychopharmacol. 2024 Oct;32(5):604-614. doi: 10.1037/pha0000719. Epub 2024 May 30. Exp Clin Psychopharmacol. 2024. PMID: 38815113
-
Assessment of abuse liability and switching potential of menthol-flavored pod-based electronic nicotine delivery systems among US adults who smoke cigarettes.Drug Alcohol Depend. 2024 May 1;258:111279. doi: 10.1016/j.drugalcdep.2024.111279. Epub 2024 Apr 2. Drug Alcohol Depend. 2024. PMID: 38614020 Clinical Trial.
-
Assessment of human abuse potential of an unflavored, sucralose-sweetened electronic cigarette in combustible cigarette smokers.Exp Clin Psychopharmacol. 2024 Oct;32(5):588-603. doi: 10.1037/pha0000720. Epub 2024 May 30. Exp Clin Psychopharmacol. 2024. PMID: 38815111
-
Human abuse liability assessment of e-cigarettes: Why, what and how?Drug Test Anal. 2023 Oct;15(10):1211-1221. doi: 10.1002/dta.3251. Epub 2022 Mar 30. Drug Test Anal. 2023. PMID: 35302289 Review.
-
Electronic cigarette substitution in the experimental tobacco marketplace: A review.Prev Med. 2018 Dec;117:98-106. doi: 10.1016/j.ypmed.2018.04.026. Epub 2018 Apr 24. Prev Med. 2018. PMID: 29702131 Free PMC article. Review.
References
-
- Girvalaki C, Vardavas A, Tzatzarakis M, Kyriakos CN, Nikitara K, Tsatsakis AM, Vardavas CI. Compliance of e-cigarette refill liquids with regulations on labelling, packaging and technical design characteristics in nine European member states. Tob Control 2020;29(5):531–536. doi: 10.1136/tobaccocontrol-2019-055061. - DOI - PubMed
-
- Moore G, Hallingberg B, Brown R, McKell J, Van Godwin J, Bauld L, Gray L, Maynard O, Mackintosh AM, Munafò M, Blackwell A, Lowthian E, Page N. Impacts of EU Tobacco Products Directive regulations on use of e-cigarettes in adolescents in Great Britain: a natural experiment evaluation. Public Health Res (Southampt) 2023;11(5):1–102. doi: 10.3310/WTMH3198. - DOI - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous